Potenciálne možnosti využitia kreatinfosfátu vo vnútornom lekárstve
[Potential possibility of phosphocreatine usage in internal medicine]
Jazyk čeština Země Česko Médium print
Typ dokumentu časopisecké články, přehledy
PubMed
30823835
PII: 107913
- Klíčová slova
- ATP - ischemia - phosphagens - phosphocreatine,
- MeSH
- adenosintrifosfát MeSH
- energetický metabolismus * MeSH
- fosfokreatin * terapeutické užití MeSH
- lidé MeSH
- myokard MeSH
- srdeční selhání farmakoterapie MeSH
- vnitřní lékařství trendy MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- adenosintrifosfát MeSH
- fosfokreatin * MeSH
Adenosintriphosphate is basic unit of cellular energetics, although during situations of high energy demand, cell had developed metabolic inert molecules - phosphagens - including phosphocreatine. Nowadays there are not so many recent publications describing positive effect of phosphocreatine supplementation., its potential benefit in supplementation is mainly in cardiology - acute myocardial infarction, acute or chronic heart failure. Another field of medicine with potential use of phosphocreatine is nephrology - in dialysis patients, or in psotemnopausal women in prevention of osteoporosis. In following article, we present review of studies describing positive effect of using phosphocreatine in specific group of patients in internal medicine. Key words: ATP - ischemia - phosphagens - phosphocreatine.